Status:
COMPLETED
A Postmarket Clinical Follow Up Study (PMCF) to Evaluate the Safety and Performance of VERIFORTE/Granudacyn® Med Wound Irrigation Solution.
Lead Sponsor:
P.G.F. Industry Solutions GmbH
Collaborating Sponsors:
WPM - Wund Pflege Management Ges.m.b.H
Conditions:
Wounds
Eligibility:
All Genders
18+ years
Brief Summary
In the course of this clinical trial, it was shown that the use of Granudacyn/VERIFORTE med wound irrigation solution in the course of adjuvant therapy supports wound healing through mechanical irriga...
Detailed Description
Aim of this clinical trial was to collect clinical data on the performance and safety of the use of Granudacyn/VERIFORTE med as a wound irrigation solution, for cleansing and irrigation of acute, chro...
Eligibility Criteria
Inclusion
- Presence of a documented case report within the indication, which enables a retrospective evaluation of the target variables.
- Subjects are ≥ 18 years of age.
- Gender: All.
Exclusion
- Vulnerable persons
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06083740
Start Date
November 1 2022
End Date
June 1 2023
Last Update
October 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PGF Industry Solutions GmbH
Salzburg, Austria